{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:06:49Z","timestamp":1791198409501,"version":"4.1.0"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1996,1]]},"abstract":"<jats:p>Studies to determine if Toxoplasma gondii-specific human T cells lyse parasite-infected cells have yielded conflicting results. Furthermore, attempts to obtain human cytotoxic CD8+ T lymphocytes have been difficult because of the lack of a reproducible system for their generation. By using paraformaldehyde-fixed, T. gondii-infected peripheral blood mononuclear cells as antigen-presenting cells, we developed a method whereby T. gondii-specific T-cell lines can be reproducibly generated. Six T. gondii-specific T-cell lines were generated from an individual chronically infected with T. gondii. Cytofluorometric analysis of these lines revealed &gt; 99% CD3+, 85 to 95% CD3+ alpha beta T-cell-receptor-positive (TCR+), 5 to 9% CD3+ gamma delta TCR+, 50 to 70% CD4+, and 20 to 40% CD8+ cells when cells were examined during the first 3 weeks of stimulation and &gt;99% CD3+, &gt;99% CD3+ alpha beta TCR+, &lt; 1% CD3+ gamma delta TCR+, 20 to 40% CD4+, and 60 to 80% CD8+ cells when cells were examined between 5 and 11 weeks. Both CD4+ and CD8+ T cells had remarkable cytotoxic activity against T. gondii-infected target cells (30 to 50% specific Cr release at an effector-to-target ratio of 30:1) but not against uninfected target cells ( &lt; 10% at an effector-to-target ratio of 30:1). Cytotoxic activity by the whole T-cell lines was not T. gondii strain specific. Whole T-cell lines were cytotoxic for target cells infected with the C56 and ME49 strains and the RH strain (which was used to infect peripheral blood mononuclear cells). T. gondii-specific T-cell lines displayed the predominant expression of V beta 7 TCR. The CDR3 regions of the V beta 7 TCRs of these T-cell lines showed a striking degree of sequence identity (oligoclonality). T-cell lines obtained by the method reporter here can be used to characterize functional activity of T-lymphocyte subsets in humans infected with T. gondii.<\/jats:p>","DOI":"10.1128\/iai.64.1.176-181.1996","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T18:52:44Z","timestamp":1578336764000},"page":"176-181","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":54,"title":["Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells"],"prefix":"10.1128","volume":"64","author":[{"given":"J G","family":"Montoya","sequence":"first","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K E","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Clayberger","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Moody","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Remington","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Talib","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Subauste","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California 94301, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/iai.64.1.176-181.1996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/iai.64.1.176-181.1996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:39:17Z","timestamp":1646469557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/iai.64.1.176-181.1996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["10.1128\/iai.64.1.176-181.1996"],"URL":"https:\/\/doi.org\/10.1128\/iai.64.1.176-181.1996","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]},"assertion":[{"value":"1996-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}